Fellowship · Los Angeles, CA
Sponsored by Children's Hospital Los Angeles
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.
Gastroenterology · 2025 · 144 citations · Rohit Kohli
Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: A Systematic Review and Meta-Analysis.
Environmental health perspectives · 2022 · 331 citations · Rohit Kohli
AASLD Practice Statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children.
Hepatology (Baltimore, Md.) · 2025 · 57 citations · Rohit Kohli
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.
The lancet. Gastroenterology & hepatology · 2022 · 154 citations · Nisreen Soufi
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025.
Obesity pillars · 2025 · 37 citations · Rohit Kohli
Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
The lancet. Gastroenterology & hepatology · 2024 · 53 citations ·
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.
Alimentary pharmacology & therapeutics · 2024 · 37 citations · Nisreen Soufi
Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
Journal of pediatric gastroenterology and nutrition · 2024 · 17 citations · Beth Carter